Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020)

被引：4
|
作者：
Sader, Helio S. [1 ]
Castanheira, Mariana [1 ]
Duncan, Leonard R. [1 ]
Mendes, Rodrigo E. [1 ]
机构：
[1] JMI Labs, North Liberty, IA 52317 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2023年 / 105卷 / 01期
关键词：
MRSA; skin and skin structure infection; pneumonia; ceftaroline; Staphylococcus aureus; VANCOMYCIN;
D O I：
10.1016/j.diagmicrobio.2022.115820
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Ceftaroline and comparators were tested against 9,268 Staphylococcus aureus isolates from 33 United States hospitals (2018-2020). Ceftaroline (MIC50/90, 0.25/1 mg/L) susceptibility ranged from 95.4% (pneumonia) to 98.5% (skin and skin structure) and was 97.2% overall. Ceftaroline retained potent and broad-spectrum activ-ity against methicillin-resistant isolates, with a 93.4% overall susceptibility. (c) 2022 Published by Elsevier Inc.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019-2020)
    Mendes, Rodrigo E.
    Arends, S. J. Ryan
    Streit, Jennifer M.
    Critchley, Ian
    Cotroneo, Nicole
    Castanheira, Mariana
    MICROBIOLOGY SPECTRUM, 2023, 11 (01):
  • [42] Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States
    Jones, ME
    Staples, AM
    Critchley, I
    Thornsberry, C
    Heinze, P
    Engler, HD
    Sahm, DF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) : 2645 - 2652
  • [43] Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers
    Mendes, Rodrigo E.
    Sader, Helio S.
    Deshpande, Lalitagauri
    Jones, Ronald N.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 60 (04) : 433 - 436
  • [44] Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014
    Pfaller, M. A.
    Sader, H. S.
    Flamm, R. K.
    Castanheira, M.
    Mendes, Rodrigo E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (02) : 199 - 204
  • [45] In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from US Medical Centers by Census Region, 2014
    Huband, Michael D.
    Castanheira, Mariana
    Flamm, Robert K.
    Farrell, David J.
    Jones, Ronald N.
    Sader, Helio S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (04) : 2537 - 2541
  • [46] In vitro activity of telavancin against Staphylococcus aureus causing pneumonia or skin and skin structure infections with concomitant bloodstream infections in United States hospitals (2012-2016)
    Duncan, Leonard R.
    Flamm, Robert K.
    Sader, Helio S.
    Mendes, Rodrigo E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 93 (02) : 167 - 170
  • [47] Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine US Medical Centers from 2002 to 2006
    Sader, Helio S.
    Fey, Paul D.
    Fish, Douglas N.
    Limaye, Ajit P.
    Pankey, George
    Rahal, James
    Rybak, Michael J.
    Snydman, David R.
    Steed, Lisa L.
    Waites, Ken
    Jones, Ronald N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4127 - 4132
  • [48] In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 US Medical Centers (2015): Potency Analysis by US Census Divisions
    Pfaller, Michael A.
    Sader, Helio S.
    Flamm, Robert K.
    Castanheira, Mariana
    Smart, Jennifer I.
    Mendes, Rodrigo E.
    MICROBIAL DRUG RESISTANCE, 2017, 23 (06) : 718 - 726
  • [49] Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016
    Sader, Helio S.
    Castanheira, Mariana
    Duncan, Leonard R.
    Flamm, Robert K.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 92 (01) : 69 - 74
  • [50] Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020-2022)
    Sader, Helio S.
    Mendes, Rodrigo E.
    Ryan Arends, S. J.
    Doyle, Timothy B.
    Castanheira, Mariana
    BMC PULMONARY MEDICINE, 2025, 25 (01):
12345